The anti-viral protein Shiftless blocks p-body formation during KSHV infection. [PDF]
Hatfield D +3 more
europepmc +1 more source
Remodeling of Metabolic and Secretory Organelles During Oncogenic and Oncomodulatory Viral Infections. [PDF]
Rodriguez W, Cristea IM.
europepmc +1 more source
KSHV- and EBV-associated germinotropic lymphoproliferative disorder [PDF]
Cabecadas, J +11 more
core +1 more source
Spatial and bulk transcriptomics reveal distinct molecular signatures in Kaposi sarcoma with and without other KSHV-associated diseases. [PDF]
Chadwick Q +14 more
europepmc +1 more source
HHV-8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions. [PDF]
Mularoni A +9 more
europepmc +1 more source
Roles of the cGAS-STING signaling pathway in viral latency. [PDF]
Wu Q, Xu Q, Liu J, Zhao T.
europepmc +1 more source
Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions. [PDF]
Bratl K, Butters C, Webb K, Schäfer G.
europepmc +1 more source
KSHV and cancer: understanding the oncogenic machinery for next-generation diagnostic tools and therapies. [PDF]
da Silva JVGO, de Oliveira Santos E.
europepmc +1 more source
Inhibiting HSP27 activates the XBP1s/CerS1 interplay, which triggers DRP1-driven mitophagy, thereby protecting against cell death and promoting the KSHV lytic cycle in primary effusion lymphoma cells. [PDF]
Gonnella R +8 more
europepmc +1 more source
EBV+ and Kaposi's Sarcoma Herpesvirus-Associated Multicentric Castleman Disease in a Patient With HIV Infection: A Case Report. [PDF]
Huang MY +5 more
europepmc +1 more source

